Eastwood Bio-Medical Canada Q3 Revenue Rises 19.2% to C$0.149 Million as Loss Widens

Eastwood Bio-Medical Canada Inc. (EBM.V) reported a third-quarter net loss of C$0.067 million, or C$0.01 per share, widening from a C$0.057 million loss a year earlier, the company said on September 30, 2026. Revenue for the period rose 19.2% to C$0.149 million from C$0.125 million in the prior-year quarter. Per-share results were unchanged at a loss of C$0.01, as the larger net loss did not alter the per-share figure. All figures are reported under GAAP.